Constanza Vásquez-Doorman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Constanza Vásquez-Doorman has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- David Gonzalez
Departamento de Ciencias Químicas y Biológicas, Facultad de Ciencias de la Salud, Universidad Bernardo O’Higgins, Santiago, Chile
2 shared publications - Adolfo Luna
Departamento de Ciencias Químicas y Biológicas, Facultad de Ciencias de la Salud, Universidad Bernardo O’Higgins, Santiago 8370854, RM, Chile
1 shared publication Andrés Lagos-Basoalto
Departamento de Biología, Facultad de Ciencias, Universidad de Chile, Santiago, Chile
1 shared publication- Marcela Torrejón
Sociedad de Biología del Desarrollo de Chile, Santiago, Chile; Laboratory of Signaling and Development, Group for the Study of Developmental Processes, Department of Biochemistry and Molecular Biology, Faculty of Biological Sciences, Universidad de Concepción, Concepción, Chile
1 shared publication Marcia Gaete
Sociedad de Biología del Desarrollo de Chile, Santiago, Chile; Center for Studies and Innovation in Dentistry, Faculty of Dentistry, Universidad Finis Terrae, Santiago, Chile
1 shared publicationMiguel L. Allende
Departamento de Biología, Facultad de Ciencias, Universidad de Chile, Santiago, Chile
1 shared publication
Latest Publications
- Open Access
- 28 March 2026
- Published by Springer Nature in BMC Ecology and Evolution
- Vol. 26 (1)
Biodiversity of freshwater planarians (Platyhelminthes, Tricladida, Dugesiidae) in Chile: exploration of unknown species
Background: Freshwater planarians (Tricladida) are widely used as model organisms in regeneration biology, invasion ecology, ecotoxicology, and systematics. Despite this relevance, their diversity remains poorly documented in large regions of South America. In Chile, only five freshwater planarian species have been formally described, a number that likely reflects limited sampling rather than true diversity. Given Chile’s pronounced latitudinal extent, biogeographic complexity, and environmental heterogeneity, freshwater planarian diversity is expected to be substantially underestimated. Here, we provide a first molecular-based assessment of Chilean freshwater planarians by sampling previously unexplored localities and integrating external morphology with phylogenetic and species delimitation analyses. Results: Specimens were collected from seven freshwater habitats spanning northern and central Chile, including high-altitude Altiplano environments and a geothermal field. External morphology was consistent with assignment to the genus Girardia , a conclusion supported by BLAST and BOLD searches. Phylogenetic analyses based on mitochondrial (COI) and nuclear (EF1-α) markers recovered three major Chilean clades with strong support, corresponding broadly to geographic regions. Altiplano populations formed a previously unreported monophyletic lineage within Girardia , suggesting isolation-driven diversification in extreme environments. Molecular species delimitation using ASAP, GMYC, and bPTP identified six putative species: Girardia sp. El Tatio, Girardia sp. Lauca/Chungará/Ascotán, Girardia sp. Calafquén, Girardia sp. OHP/LTB, Girardia sp. Los Lagos, and Girardia sp. LPM. Conclusion: Our results reveal that freshwater planarian diversity in Chile is far greater than currently recognized and that Girardia exhibits pronounced geographic structuring across the country. The discovery of multiple genetically distinct lineages, including in high-altitude and geothermal environments, highlights the role of geographic isolation and environmental heterogeneity in shaping diversification. Although formal species descriptions will require internal anatomy and additional molecular data, this study provides a critical framework for future taxonomic, evolutionary, and ecological research on South American freshwater planarians and underscores the importance of expanding biodiversity surveys into understudied regions.
- 28 March 2026
- Published by Springer Nature in BMC Ecology and Evolution
- Vol. 26 (1)
Open AccessBiodiversity of freshwater planarians (Platyhelminthes, Tricladida, Dugesiidae) in Chile: exploration of unknown species
Background: Freshwater planarians (Tricladida) are widely used as model organisms in regeneration biology, invasion ecology, ecotoxicology, and systematics. Despite this relevance, their diversity remains poorly documented in large regions of South America. In Chile, only five freshwater planarian species have been formally described, a number that likely reflects limited sampling rather than true diversity. Given Chile’s pronounced latitudinal extent, biogeographic complexity, and environmental heterogeneity, freshwater planarian diversity is expected to be substantially underestimated. Here, we provide a first molecular-based assessment of Chilean freshwater planarians by sampling previously unexplored localities and integrating external morphology with phylogenetic and species delimitation analyses. Results: Specimens were collected from seven freshwater habitats spanning northern and central Chile, including high-altitude Altiplano environments and a geothermal field. External morphology was consistent with assignment to the genus Girardia , a conclusion supported by BLAST and BOLD searches. Phylogenetic analyses based on mitochondrial (COI) and nuclear (EF1-α) markers recovered three major Chilean clades with strong support, corresponding broadly to geographic regions. Altiplano populations formed a previously unreported monophyletic lineage within Girardia , suggesting isolation-driven diversification in extreme environments. Molecular species delimitation using ASAP, GMYC, and bPTP identified six putative species: Girardia sp. El Tatio, Girardia sp. Lauca/Chungará/Ascotán, Girardia sp. Calafquén, Girardia sp. OHP/LTB, Girardia sp. Los Lagos, and Girardia sp. LPM. Conclusion: Our results reveal that freshwater planarian diversity in Chile is far greater than currently recognized and that Girardia exhibits pronounced geographic structuring across the country. The discovery of multiple genetically distinct lineages, including in high-altitude and geothermal environments, highlights the role of geographic isolation and environmental heterogeneity in shaping diversification. Although formal species descriptions will require internal anatomy and additional molecular data, this study provides a critical framework for future taxonomic, evolutionary, and ecological research on South American freshwater planarians and underscores the importance of expanding biodiversity surveys into understudied regions.
- Open Access
Current Knowledge in Planarian Glia and Its Future Implications in Modeling Neurodegenerative Diseases
Neurodegenerative diseases are characterized by progressive loss of neurons and remain largely incurable. Numerous mammalian models have been developed to study the mechanisms underlying their physiopathology; however, their high cost, complexity and time requirements highlight the need for alternative systems. Glial cells are increasingly recognized as key contributors to neurodegenerative disease progression through non-cell autonomous mechanisms. Planarians possess a nervous system with diverse neuronal subtypes and glial cells, offering an attractive combination of evolutionary conservation and remarkable regenerative capacity. Unlike mammalian glia, planarian glia originate from phagocytic progenitors and exhibit distinctive molecular markers, including if-1, cali and cathepsin. Emerging evidence suggests that planarian glia may contribute to neurotransmitter homeostasis, neuron–glia interactions and phagocytic activity. Additionally, planarians display robust and quantifiable behavioral responses, making them well suited for modeling neurodegenerative disease. In this review, we summarize the current findings regarding neuronal subtypes and glial cells in planaria, emphasizing their relevance as a model system. Further research into planarian glia will be crucial for understanding their roles in pathological contexts and for exploring their potential applications in neurodegenerative diseases research. Planarian simplicity, regenerative capacity, and compatibility with high-throughput approaches position planarians as a powerful model for investigating the cellular and molecular mechanisms underlying neurodegenerative diseases and for identifying potential therapeutic targets.
Open AccessCurrent Knowledge in Planarian Glia and Its Future Implications in Modeling Neurodegenerative Diseases
Neurodegenerative diseases are characterized by progressive loss of neurons and remain largely incurable. Numerous mammalian models have been developed to study the mechanisms underlying their physiopathology; however, their high cost, complexity and time requirements highlight the need for alternative systems. Glial cells are increasingly recognized as key contributors to neurodegenerative disease progression through non-cell autonomous mechanisms. Planarians possess a nervous system with diverse neuronal subtypes and glial cells, offering an attractive combination of evolutionary conservation and remarkable regenerative capacity. Unlike mammalian glia, planarian glia originate from phagocytic progenitors and exhibit distinctive molecular markers, including if-1, cali and cathepsin. Emerging evidence suggests that planarian glia may contribute to neurotransmitter homeostasis, neuron–glia interactions and phagocytic activity. Additionally, planarians display robust and quantifiable behavioral responses, making them well suited for modeling neurodegenerative disease. In this review, we summarize the current findings regarding neuronal subtypes and glial cells in planaria, emphasizing their relevance as a model system. Further research into planarian glia will be crucial for understanding their roles in pathological contexts and for exploring their potential applications in neurodegenerative diseases research. Planarian simplicity, regenerative capacity, and compatibility with high-throughput approaches position planarians as a powerful model for investigating the cellular and molecular mechanisms underlying neurodegenerative diseases and for identifying potential therapeutic targets.
- 16 June 2025
- Published by Elsevier in Differentiation
- Vol. 144, 100882
Developmental biology in Chile: an open window to Latin America and the world
- 16 June 2025
- Published by Elsevier in Differentiation
- Vol. 144, 100882
Developmental biology in Chile: an open window to Latin America and the world
- Open Access
- 6 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 1962
Modeling Spinal Muscular Atrophy in Zebrafish: Current Advances and Future Perspectives
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease characterized by degeneration of lower motor neurons (LMNs), causing muscle weakness, atrophy, and paralysis. SMA is caused by mutations in the Survival Motor Neuron 1 (SMN1) gene and can be classified into four subgroups, depending on its severity. Even though the genetic component of SMA is well known, the precise mechanisms underlying its pathophysiology remain elusive. Thus far, there are three FDA-approved drugs for treating SMA. While these treatments have shown promising results, their costs are extremely high and unaffordable for most patients. Thus, more efforts are needed in order to identify novel therapeutic targets. In this context, zebrafish (Danio rerio) stands out as an ideal animal model for investigating neurodegenerative diseases like SMA. Its well-defined motor neuron circuits and straightforward neuromuscular structure offer distinct advantages. The zebrafish’s suitability arises from its low-cost genetic manipulation and optical transparency exhibited during larval stages, which facilitates in vivo microscopy. This review explores advancements in SMA research over the past two decades, beginning with the creation of the first zebrafish model. Our review focuses on the findings using different SMA zebrafish models generated to date, including potential therapeutic targets such as U snRNPs, Etv5b, PLS3, CORO1C, Pgrn, Cpg15, Uba1, Necdin, and Pgk1, among others. Lastly, we conclude our review by emphasizing the future perspectives in the field, namely exploiting zebrafish capacity for high-throughput screening. Zebrafish, with its unique attributes, proves to be an ideal model for studying motor neuron diseases and unraveling the complexity of neuromuscular defects.
- 6 February 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (4) , 1962
Open AccessModeling Spinal Muscular Atrophy in Zebrafish: Current Advances and Future Perspectives
Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease characterized by degeneration of lower motor neurons (LMNs), causing muscle weakness, atrophy, and paralysis. SMA is caused by mutations in the Survival Motor Neuron 1 (SMN1) gene and can be classified into four subgroups, depending on its severity. Even though the genetic component of SMA is well known, the precise mechanisms underlying its pathophysiology remain elusive. Thus far, there are three FDA-approved drugs for treating SMA. While these treatments have shown promising results, their costs are extremely high and unaffordable for most patients. Thus, more efforts are needed in order to identify novel therapeutic targets. In this context, zebrafish (Danio rerio) stands out as an ideal animal model for investigating neurodegenerative diseases like SMA. Its well-defined motor neuron circuits and straightforward neuromuscular structure offer distinct advantages. The zebrafish’s suitability arises from its low-cost genetic manipulation and optical transparency exhibited during larval stages, which facilitates in vivo microscopy. This review explores advancements in SMA research over the past two decades, beginning with the creation of the first zebrafish model. Our review focuses on the findings using different SMA zebrafish models generated to date, including potential therapeutic targets such as U snRNPs, Etv5b, PLS3, CORO1C, Pgrn, Cpg15, Uba1, Necdin, and Pgk1, among others. Lastly, we conclude our review by emphasizing the future perspectives in the field, namely exploiting zebrafish capacity for high-throughput screening. Zebrafish, with its unique attributes, proves to be an ideal model for studying motor neuron diseases and unraveling the complexity of neuromuscular defects.